Agile Therapeutics AGRX Stock
Agile Therapeutics Price Chart
Agile Therapeutics AGRX Financial and Trading Overview
| Agile Therapeutics stock price | 1.51 USD |
| Previous Close | 3.48 USD |
| Open | 3.3 USD |
| Bid | 0 USD x 4000 |
| Ask | 0 USD x 800 |
| Day's Range | 3.07 - 3.4 USD |
| 52 Week Range | 3.07 - 141 USD |
| Volume | 256.12K USD |
| Avg. Volume | 100.36K USD |
| Market Cap | 3.66M USD |
| Beta (5Y Monthly) | 1.144366 |
| PE Ratio (TTM) | 0.031847134 |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 250 USD |
AGRX Valuation Measures
| Enterprise Value | 1.34M USD |
| Trailing P/E | 0.031847134 |
| Forward P/E | -0.29545453 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.28315145 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.103 |
| Enterprise Value/EBITDA | -0.042 |
Trading Information
Agile Therapeutics Stock Price History
| Beta (5Y Monthly) | 1.144366 |
| 52-Week Change | -94.34% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 141 USD |
| 52 Week Low | 3.07 USD |
| 50-Day Moving Average | 5.58 USD |
| 200-Day Moving Average | 11.19 USD |
AGRX Share Statistics
| Avg. Volume (3 month) | 100.36K USD |
| Avg. Daily Volume (10-Days) | 463.59K USD |
| Shares Outstanding | 1.13M |
| Float | 988.41K |
| Short Ratio | 2.07 |
| % Held by Insiders | 0.0040% |
| % Held by Institutions | 3.53% |
| Shares Short | 79.05K |
| Short % of Float | 7.01% |
| Short % of Shares Outstanding | 7.00% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -157.83% |
| Operating Margin (ttm) | -251.77% |
| Gross Margin | 43.47% |
| EBITDA Margin | -243.73% |
Management Effectiveness
| Return on Assets (ttm) | -94.68% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 12.94M USD |
| Revenue Per Share (ttm) | 20.07 USD |
| Quarterly Revenue Growth (yoy) | 116.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | -31530000 USD |
| Net Income Avi to Common (ttm) | -20417000 USD |
| Diluted EPS (ttm) | 102.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.43M USD |
| Total Cash Per Share (mrq) | 4.48 USD |
| Total Debt (mrq) | 2.22M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.589 |
| Book Value Per Share (mrq) | -10.121 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -22791000 USD |
| Levered Free Cash Flow (ttm) | -9467750 USD |
Profile of Agile Therapeutics
| Country | United States |
| State | NJ |
| City | Princeton |
| Address | 500 College Road East |
| ZIP | 08540 |
| Phone | 609 683 1880 |
| Website | https://www.agiletherapeutics.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 22 |
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. The company was incorporated in 1997 and is headquartered in Princeton, New Jersey.
Q&A For Agile Therapeutics Stock
What is a current AGRX stock price?
Agile Therapeutics AGRX stock price today per share is 1.51 USD.
How to purchase Agile Therapeutics stock?
You can buy AGRX shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Agile Therapeutics?
The stock symbol or ticker of Agile Therapeutics is AGRX.
Which industry does the Agile Therapeutics company belong to?
The Agile Therapeutics industry is Drug Manufacturers-Specialty & Generic.
How many shares does Agile Therapeutics have in circulation?
The max supply of Agile Therapeutics shares is 6.9M.
What is Agile Therapeutics Price to Earnings Ratio (PE Ratio)?
Agile Therapeutics PE Ratio is 0.00000000 now.
What was Agile Therapeutics earnings per share over the trailing 12 months (TTM)?
Agile Therapeutics EPS is 0 USD over the trailing 12 months.
Which sector does the Agile Therapeutics company belong to?
The Agile Therapeutics sector is Healthcare.
Agile Therapeutics AGRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17366.13 USD — |
-0.1
|
9.58B USD — | 17128.71 USD — | 17467.35 USD — | — - | 9.58B USD — |
| NASDAQ Composite Total Return I XCMP | 21258.23 USD — |
-0.1
|
— — | 20967.6 USD — | 21382.13 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 102.11 USD — |
-0.04
|
— — | 100.72 USD — | 103.65 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 931.02 USD — |
+0.81
|
— — | 921.75 USD — | 934.48 USD — | — - | — — |
- {{ link.label }} {{link}}